---
title: "Cost-Benefit Analysis of Underwriting Screening for Opioid Risks"
date: 2018-02-01T00:13:01+0000
author: matt
draft: True
---
The question we hear from underwriters is: is it financially feasible to screen all life applicants for opioid use? The intention of this paper is to provide context for these concerns by exploring various screening options, and to provide a cost-benefit analysis that can assist underwriting departments in determining when to use such screening tools. 

[ Cost-Benefit Analysis of Underwriting Screening for Opioid Risks ]( https://www.munichre.com/site/marclife-mobile/get/documents_E1527597204/marclife/assset.marclife/Documents/Publications/cost-benefit-analysis-of-underwriting-screening-WP_1-19-18.pdf )
